This device will use a combination or existing “on the shelf” technologies for specific use of detecting molecular signatures/molecular fingerprints of COVID, Virus, and all strains of the virus, microorganisms, pathogens, disease, disorders, and cancer by type by sampling the specific odor with an electronic nose, match the molecular signature/molecular fingerprints with digitized odors in a database, and produce alarms audible, audio, and communication alarms with other data regarding a positive match in the database of digitized unique molecular signatures/molecular fingerprints in the database.